Association of adiponectin levels and insulin demand in critically ill patients

References

• Langouche L van den Berghe G Glucose metabolism and insulin therapy Crit Care Clin 2006 22 1 119 129 16399023
   PubMed Web of Science ®Google Scholar
• Van den Berghe G Wilmer A Hermans G Intensive insulin therapy in the medical ICU N Engl J Med 2006 354 5 449 461 16452557
   PubMed Web of Science ®Google Scholar
• Fritsche L Weigert C Häring HU Lehmann R How insulin receptor substrate proteins regulate the metabolic capacity of the liver –implications for health and disease Curr Med Chem 2008 15 13 1316 1329 18537611
   PubMed Web of Science ®Google Scholar
• Rabe K Lehrke M Parhofer KG Broedl UC Adipokines and insulin resistance Mol Med 2008 14 11–12 741 751 19009016
   PubMed Web of Science ®Google Scholar
• Ouchi N Kihara S Funahashi T Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue Circulation 2003 107 5 671 674 12578865
   PubMed Web of Science ®Google Scholar
• Dyck DJ Adipokines as regulators of muscle metabolism and insulin sensitivity Appl Physiol Nutr Metab 2009 34 3 396 402 19448705
   PubMed Web of Science ®Google Scholar
• Hillenbrand A Knippschild U Weiss M Sepsis induced changes of adipokines and cytokines – septic patients compared to morbidly obese patients BMC Surg 2010 10 1 26 20825686
   PubMed Web of Science ®Google Scholar
• Arita Y Kihara S Ouchi N Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 1999 257 1 79 83 10092513
   PubMed Web of Science ®Google Scholar
• Li S Shin HJ Ding EL van Dam RM Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis JAMA 2009 302 2 179 188 19584347
   PubMed Web of Science ®Google Scholar
• Bone RC Balk RA Cerra FB Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Chest 1992 101 6 1644 1655 1303622
   PubMed Web of Science ®Google Scholar
• Le Gall JR Lemeshow S Saulnier F A New Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study JAMA 1993 270 2957 2963 8254858
   PubMed Web of Science ®Google Scholar
• Teasdale G Jennett B Assessment of coma and impaired consciousness. A practical scale Lancet 1974 2 81 84 4136544
   PubMed Web of Science ®Google Scholar
• Janssens U Dujardin R Graf J Value of SOFA (Sequential Organ Failure Assessment) score and total maximum SOFA score in 812 patients with acute cardiovascular disorders Critical Care 2001 5 suppl 1 P225x
   Google Scholar
• Matsuzawa Y Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease Atheroscler Suppl 2005 6 2 7 14 15823491
   PubMed Web of Science ®Google Scholar
• Yu YH Ginsberg HN Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue Circ Res 2005 96 10 1042 1052 15920027
   PubMed Web of Science ®Google Scholar
• Basu R Pajvani UB Rizza RA Scherer PE Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects Diabetes 2007 56 8 2174 2177 17513700
   PubMed Web of Science ®Google Scholar
• Laferrère B Heshka S Wang K Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes Diabetes Care 2007 30 7 1709 1716 17416796
   PubMed Web of Science ®Google Scholar
• Verspohl EJ Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors Pharmacol Ther 2009 124 1 113 138 19545590
   PubMed Web of Science ®Google Scholar
• Broglio F Arvat E Benso A Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans J Clin Endocrinol Metab 2001 86 10 5083 5086 11600590
   PubMed Web of Science ®Google Scholar
• Nakahara K Okame R Katayama T Miyazato M Kangawa K Murakami N Nutritional and environmental factors affecting plasma ghrelin and leptin levels in rats J Endocrinol 2010 207 1 95 103 20631048
   PubMed Web of Science ®Google Scholar
• Van den Hoek AM Heijboer AC Voshol PJ Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice Am J Physiol Endocrinol Metab 2007 292 1 E238 E245 16940471
   PubMed Web of Science ®Google Scholar
• Billyard T McTernan P Kumar S Potential therapies based on antidiabetic peptides Best Pract Res Clin Endocrinol Metab 2007 21 4 641 655 18054740
   PubMed Web of Science ®Google Scholar
• Lehrke M Broedl UC Biller-Friedmann IM Serum concentrations of cortisol, interleukin 6, leptin and adiponectin predict stress induced insulin resistance in acute inflammatory reactions Crit Care 2008 12 6 R157 19087258
   PubMed Web of Science ®Google Scholar
• Nagaev I Bokarewa M Tarkowski A Smith U Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes PLoS ONE 1 2006 e31
   Web of Science ®Google Scholar
• Pang SS Le YY Role of resistin in inflammation and inflammation-related diseases Cell Mol Immunol 2006 3 1 29 34 16549046
   PubMed Web of Science ®Google Scholar
• Steppan CM Lazar MA Resistin and obesity-associated insulin resistance Trends Endocrinol Metab 2002 13 1 18 23 11750858
   PubMed Web of Science ®Google Scholar
• Maury E Brichard SM Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome Mol Cell Endocrinol 2010 314 1 1 16 19682539
   PubMed Web of Science ®Google Scholar
• Cook JR Semple RK Hypoadiponectinemia – cause or consequence of human “insulin resistance”? J Clin Endocrinol Metab 2010 95 4 1544 1554 20164291
   PubMed Web of Science ®Google Scholar